TABLE 1

Details on All 41 Patients

Patient no.DiseaseMass lesionTissueSUVResidual 18F-FDG activity
BladderUreter
1UCerPrimary lesionSCC2.09
2UCerPrimary lesionSCC3.41+
3UCerPrimary lesionSCC4.35
4UCerPrimary lesionSCC4.35
5UCerPrimary lesionSCC4.82
6UCerPrimary lesionSCC5.96
7UCerPrimary lesionSCC6.56+
8UCerPrimary lesionSCC7.19
9UCerPrimary lesionSCC7.56+
10UCerPrimary lesionSCC7.97
11UCerPrimary lesionSCC8.15
12UCerPrimary lesionSCC10.83
13UCerPrimary lesionSCC11.00
14UCerPrimary lesionSCC11.53
15UCerPrimary lesionSCC13.58+
16RUCerLocal recurrenceSCC2.14
17RUCerLocal recurrenceClear cell adenocarcinoma2.14
18RUCerLocal recurrenceSCC2.29
19RUCerLocal recurrenceSCC2.83
20RUCerLocal recurrenceSCC3.10
21NRUCerPelvic cavityDiagnosed by clinical course0.26
22NRUCerLocal lesionDiagnosed by clinical course1.69
23NRUCerLocal lesionNo malignancy1.95+
24UCorPrimary lesionAdenocarcinoma2.64+
25UCorPrimary lesionEndometrioid adenocarcinoma2.74
26UCorPrimary lesionAdenocarcinoma4.77
27UCorPrimary lesionEndometrioid adenocarcinoma4.93
28UCorPrimary lesionAdenocarcinoma7.50
29UCorPrimary lesionEndometrioid adenocarcinoma10.06
30RUCorLocal recurrenceMetastatic adenocarcinoma7.60
31RUCorLocal recurrenceEndometrioid adenocarcinoma11.20
32OCPrimary lesionSerous cystadenocarcinoma6.36
33ROCRemaining ovaryYolk sac tumor recurrence2.60+
34ROCLymph nodeEndometrioid adenocarcinoma5.84
35ROCLymph nodeMucinous cystadenocarcinoma8.55
36ROCLymph nodeMucinous cystadenocarcinoma3.53
37ROCLymph nodeClear cell carcinoma5.11
38BOPrimary lesionDermoid cyst1.37+
39BOPrimary lesionFibroma3.93
40BORemaining ovaryNo malignancy1.17
41BORemaining ovaryNo malignancy1.63
  • UCer = uterine cervical carcinoma; SCC = squamous cell carcinoma; RUCer = recurrent uterine cervical carcinoma; NRUCer = nonrecurrent uterine cervical carcinoma; UCor = uterine corpus carcinoma; RUCor = recurrent uterine corpus carcinoma; OC = ovarian cancer; ROC = recurrent ovarian cancer; BO = benign ovarian tumor or no malignancy.